Skip to content

AT - MEDICALS: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

AT - MEDICALS

BE 0502.815.039
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€126,564
2024 · €128,826-€2,262
Equity
€1.1m
2024 · €948,210+€125,078
Cash
€262,175
2024 · €384,272-€122,097
Balance sheet total
€1.4m
2024 · €1.3m+€95,356

Largest movements

2024 to 2025
Assets
  • Current investments +€200,000

    up €200,000 (+100%), from €200,000 to €400,000

  • Cash -€122,097

    down €122,097 (-31.8%), from €384,272 to €262,175

    mainly Current investments (-€200,000) and Investment in fixed assets (net) (-€40,926)

  • Tangible fixed assets +€14,186

    up €14,186 (+2.6%), from €537,824 to €552,011

    of which Other tangible fixed assets: +€35,585

Equity and liabilities
  • Reserves +€126,564

    up €126,564 (+14.1%), from €895,687 to €1.0m

    of which Distributable reserves: +€126,564

  • Debts after one year -€27,911

    down €27,911 (-13.8%), from €202,201 to €174,289

Income statement
  • Gross operating margin -€13,639

    down €13,639 (-4.8%), from €284,606 to €270,967

  • Staff costs -€13,189

    down €13,189 (-18.4%), from €71,839 to €58,651

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €128,826
Gross operating margin -€13,639
Staff costs +€13,189
Depreciation -€1,439
Other operating charges +€84
Financial income -€914
Financial charges +€517
Taxes -€60
Result 2025 €126,564
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€147,762
Investment -€240,926
Financing -€28,933
Cash 2024 €384,272
Net result for the year +€126,564
Depreciation +€26,740
Smaller working-capital items +€340
Receivables within one year -€3,606
Trade debts -€1,356
Tax, wage and social debts -€747
Other debts -€721
Accrued charges and deferred income +€548
Investment in fixed assets (net) -€40,926
Current investments -€200,000
Debts after one year -€27,911
Current portion of long-term debt +€464
Contributions, distributions and other -€1,486
Cash 2025 €262,175
brings cash intakes cash out
Every line side by side 49 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,282,367 €1,377,723 +€95,356 +7.4%
Fixed assets 21/28 €537,824 €552,011 +€14,186 +2.6%
Tangible fixed assets 22/27 €537,824 €552,011 +€14,186 +2.6%
Land and buildings 22 €432,095 €417,692 -€14,404 -3.3%
Plant, machinery and equipment 23 €17,778 €15,948 -€1,830 -10.3%
Furniture and vehicles 24 €23,387 €18,221 -€5,166 -22.1%
Other tangible fixed assets 26 €64,564 €100,149 +€35,585 +55.1%
Current assets 29/58 €744,543 €825,712 +€81,170 +10.9%
Stocks and contracts in progress 3 €15,298 €15,298 +€0 0.0%
Stocks 30/36 €15,298 €15,298 +€0 0.0%
Amounts receivable within one year 40/41 €142,240 €145,846 +€3,606 +2.5%
Trade receivables 40 €142,240 €145,816 +€3,576 +2.5%
Other amounts receivable 41 - €30 +€30
Current investments 50/53 €200,000 €400,000 +€200,000 +100%
Cash at bank and in hand 54/58 €384,272 €262,175 -€122,097 -31.8%
Deferred charges and accrued income 490/1 €2,733 €2,393 -€340 -12.4%
Total equity and liabilities 10/49 €1,282,367 €1,377,723 +€95,356 +7.4%
Equity 10/15 €948,210 €1,073,288 +€125,078 +13.2%
Contributions 10/11 €12,400 €12,400 = 0.0%
Reserves 13 €895,687 €1,022,251 +€126,564 +14.1%
Tax-exempt reserves 132 €18,750 €18,750 = 0.0%
Distributable reserves 133 €876,937 €1,003,501 +€126,564 +14.4%
Investment grants 15 €40,123 €38,637 -€1,486 -3.7%
Amounts payable 17/49 €334,157 €304,435 -€29,722 -8.9%
Amounts payable after more than one year 17 €202,201 €174,289 -€27,911 -13.8%
Financial debts 170/4 €202,201 €174,289 -€27,911 -13.8%
Amounts payable within one year 42/48 €131,956 €129,597 -€2,359 -1.8%
Current portion of amounts payable after more than one year 42 €29,753 €30,218 +€464 +1.6%
Trade debts 44 €48,539 €47,184 -€1,356 -2.8%
Suppliers 440/4 €48,539 €47,184 -€1,356 -2.8%
Taxes, remuneration and social security 45 €52,942 €52,196 -€747 -1.4%
Taxes 450/3 €46,186 €45,018 -€1,168 -2.5%
Remuneration and social security 454/9 €6,756 €7,177 +€421 +6.2%
Other amounts payable 47/48 €721 - -€721
Accrued charges and deferred income 492/3 - €548 +€548
Non-recurring operating income 76A €13,288 - -€13,288
Remuneration, social security and pensions 62 €71,839 €58,651 -€13,189 -18.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €25,301 €26,740 +€1,439 +5.7%
Other operating charges 640/8 €6,376 €6,293 -€84 -1.3%
Gross operating margin 9900 €284,606 €270,967 -€13,639 -4.8%
Operating profit (loss) 9901 €181,089 €179,285 -€1,805 -1.0%
Financial income 75/76B €3,605 €2,691 -€914 -25.4%
Recurring financial income 75 €3,605 €2,691 -€914 -25.4%
Financial charges 65/66B €4,278 €3,761 -€517 -12.1%
Recurring financial charges 65 €4,278 €3,761 -€517 -12.1%
Profit (loss) for the period before taxes 9903 €180,417 €178,215 -€2,202 -1.2%
Income taxes 67/77 €51,591 €51,651 +€60 +0.1%
Profit (loss) for the period 9904 €128,826 €126,564 -€2,262 -1.8%
Profit (loss) for the period to be appropriated 9905 €128,826 €126,564 -€2,262 -1.8%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 October 2026 via checked.be.